| abstract |
The compounds of formula I are useful for the inhibition of Raf kinase. Compounds of formula I, and stereoisomers, tautomers, pros thereof, for in vitro, in situ, and in vivo diagnosis, prevention, or treatment of such disorders in mammalian cells, or related pathologies Disclosed are drugs and methods of using pharmaceutically acceptable salts. The present invention also provides a pharmaceutical composition comprising a compound of the present invention and a pharmaceutically acceptable carrier or excipient. Also provided is a method of preventing or treating a disease or disorder modulated by B-Raf, comprising administering an effective amount of a compound of the invention to a mammal in need of such treatment. |